March 26, 2019
Fina Biosolutions’ Licensee Successfully Completes a Phase 3 Study and Enters World Health Organization (WHO) Registration for Pneumosil®
Serum Institute of India completes a Phase 3 clinical trial with chemistry developed by Fina Biosolutions ROCKVILLE, Md.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/pneumococcal?src=hash”…